Navigation Links
The Only Chromogenic Medium That Detects Both Salmonella and Shigella!
Date:2/14/2011

SANTA MARIA, Calif., Feb. 14, 2011 /PRNewswire/ -- Hardy Diagnostics, an ISO certified biomedical firm, is pleased to announce the release of HardyCHROM™ SS, a highly selective chromogenic medium recommended for use as a primary screening medium for the isolation and differentiation of Salmonella and Shigella spp. from stool cultures. These two pathogens can be easily distinguished from non-pathogenic enteric bacteria based on colony color. Differentiation of Salmonella and Shigella spp. from non-pathogenic bacteria is accomplished by three mechanisms: chromogenic reactions, carbohydrate fermentation, and hydrogen sulfide production. Shigella and non-H2S producing Salmonella spp. appear as turquoise colonies. H2S producing Salmonella will develop colonies with black centers.

(Photo:  http://photos.prnewswire.com/prnh/20110214/LA44845)

HardyCHROM™ SS represents the first and only chromogenic culture medium that simultaneously detects both Salmonella and Shigella spp. while ruling out non-pathogenic enteric bacteria (both lactose and non-lactose-fermenting organisms). Most Proteus spp. do not produce black colonies (H2S) and do not produce a color change on this medium; and therefore are not confused with Salmonella and Shigella.

HardyCHROM™ SS provides superior differentiation of colonies, reduces the need for secondary testing of isolates, and thus results in less false-positive results.  HardyCHROM™ SS also allows the laboratory technologist to use fewer culture media plates when setting up stool cultures.

ABOUT HARDY DIAGNOSTICSHardy Diagnostics is an FDA licensed and ISO 13485 certified manufacturer of medical devices for microbiological procedures in both clinical and industrial laboratories. The company manufactures over 3,000 products for the culture and identification of bacteria and fungi from its Santa Maria, California headquarters. Currently over 6,000 laboratories are serviced by Hardy Diagnostics throughout the nation.

The company was founded in 1980 by Jay Hardy, a Clinical Laboratory Scientist from Santa Barbara, CA. Today, Hardy Diagnostics maintains six distribution centers throughout the U.S. and exports products to over 30 foreign distributors.

The company's mission is to partner with its laboratory customers to prevent and diagnose disease. For more information, visit http://www.HardyDiagnostics.com/HardyChromSS.htmlContact Information:Contact Person: Christopher CataniCompany Name: HARDY DIAGNOSTICSAddress: 1430 West McCoy Lane, Santa Maria, CA 93455Phone Number: (805) 346-2766, Ext: 5696Fax Number: (805) 928-2950Email Address: CataniC@HardyDiagnostics.comCompany Website: http://www.HardyDiagnostics.com/HardyChromSS.html
'/>"/>

SOURCE Hardy Diagnostics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Chromogenic Endotoxin Detection System
2. QualTech Laboratories Validates USP Protocols for Anti-Factor IIa Chromogenic Assay for Potency
3. eCareSoft Launches Comprehensive EHR for Small & Medium Hospitals
4. PharMEDium Announces Propofol, Ready-to-Use, Single Patient, Syringe Service for Operating Room Anesthesia
5. PharMEDium Hires Thomas W. Rasnic as Vice President, Quality, Regulatory Affairs and Research and Development
6. PharMEDium Elects William R. Spalding to Board of Directors
7. Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam
8. New Small and Medium Sized Enterprises Join TI Pharma by Signing Two New Projects
9. Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System
10. Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium
11. American Heart Association Rapid Access Journal Report: Implanted Monitor Accurately Detects Heart Rhythm Disturbances
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... Wegener Polyangiitis - Pipeline Review, H2 ... Polyangiitis - Pipeline Review, H2 2015, provides an ... This report provides comprehensive information on the therapeutic ... at various stages, therapeutics assessment by drug target, ... and molecule type, along with latest updates, and ...
(Date:2/4/2016)... Frontier Pharma: Chronic Obstructive Pulmonary Disease ... Chronic Obstructive Pulmonary Disease (COPD) is ... the airways and lungs. Persistent breathing difficulties and ... one of the leading causes of morbidity and ... COPD is linked to cumulative exposure to risk ...
(Date:2/4/2016)... 2016 In response to the opioid abuse epidemic, ... for Medical Products and Tobacco, along with other FDA leaders, ... approach to opioid medications. The plan will focus on policies ... pain access to effective relief. --> ... Re-examine the risk-benefit paradigm for opioids and ensure that the ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the air at King Kullen! ... assortments and packaging. This staple for Valentine’s Day is a must-have, and can be ... Valentine’s Day, not only are long-stem roses available, but also other flower bouquets, elegantly ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... of Popeyes Louisiana Kitchen restaurants, launched the 14th annual “Appetite for a Cure” ... adults with muscular dystrophy, ALS and related diseases that severely limit strength and ...
(Date:2/5/2016)... , ... February 05, 2016 , ... ... devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through ... poised to once again host, Swirl, A Wine Tasting Event at the La ...
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure today announced ... and donate to Give To Cure’s campaign that is crowdfunding clinical trials to help ... and share payments through a smart device. In 2015 alone, Venmo processed $7.5 billion ...
(Date:2/5/2016)... ... 2016 , ... Stuart Bentkover, MD, FACS is thrilled to announce ... most effective tattoo removal today, Dr. Bentkover is the only doctor in Central Massachusetts ... PicoSure has been approved by the Food and Drug Administration (FDA) as a safe ...
Breaking Medicine News(10 mins):